Research output per year
Research output per year
Personal profile
Education/Academic qualification
Genetics and Molecular Biosciences, Master's degree, Characterisation of BH3-mimetic-drug resistant acute myeloid leukaemia cell lines to identify novel drug combinations for targeted cancer therapy, University of Helsinki
1 Aug 2020 → 8 Jul 2022
Award Date: 8 Jul 2022
Fields of Science
- 3111 Biomedicine
- Functional Precision Medicine
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Efficacy of the Peptide Drug Conjugates Melflufen and OPDC3 in Venetoclax Resistant Acute Myeloid Leukemia
Kumari, R., Miettinen, J., Tambe, M., Olgac, E. J., Ruokoranta, T., Ikonen, N., Huppunen, M.-E. A., Gelius, S. S., Acs, K. & Heckman, C., 5 Nov 2024, p. 1548-1548. 1 p.Research output: Conference materials › Abstract › peer-review
Open Access -
Venetoclax triggers sublethal apoptotic signaling in venetoclax-resistant acute myeloid leukemia cells and induces vulnerability to PARP inhibition and azacitidine
Tambe, M., Unterberger, S., Kriegbaum, M. C., Vänttinen, I., Olgac, E. J., Vähä-Koskela, M., Kontro, M., Wennerberg, K. & Heckman, C. A., Oct 2024, In: Cell Death and Disease. 15, 10, 9 p., 750.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
-
Pharmacological targeting of high-risk hematological malignancies
Heckman, C. (Project manager), Adhikari, S. (Participant), Ikonen, N. (Participant), Kumari, R. (Participant), Mendoza Ortiz, E. D. (Participant), Newman, R. G. D. (Participant), Olgac, E. J. (Participant), Sergeev, P. (Participant), Srivastava, A. (Participant), Tambe, M. (Participant), Tanoli, Z. (Participant) & Tsallos, D. (Participant)
01/09/2023 → 31/08/2027
Project: Research Council of Finland: Academy Project
-
Heckman Jusélius 1/3 2023-24
Heckman, C. (Project manager), Adhikari, S. (Participant), Ikonen, N. (Participant), Mendoza Ortiz, E. D. (Participant), Olgac, E. J. (Participant), Saad, J. (Participant), Tambe, M. (Participant) & Tsallos, D. (Participant)
Sigrid Juséliuksen Säätiö @003701165704@
01/05/2023 → 30/04/2026
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
Caroline Heckman NIH subaward ISB
Heckman, C. (Project manager), Adhikari, S. (Participant), Kallio, S. J. (Participant), Kuusanmäki, H. (Participant), Miettinen, J. (Participant), Olgac, E. J. (Participant), Parsons, A. O. (Participant), Ruokoranta, T. (Participant), Sergeev, P. (Participant) & Srivastava, A. (Participant)
National Institutes of Health (NIH) OFM
01/01/2023 → 31/12/2025
Project: Other funder
-
Glykos_Heckman
Heckman, C. (Project manager) & Olgac, E. J. (Participant)
01/12/2022 → 31/05/2023
Project: Corporate funding
Activities
-
Wee1 inhibitors are active in acute myeloid leukaemia cells with acquired resistance to BCL2 inhibitor venetoclax
Olgac, E. J. (Speaker)
29 Oct 2023 → 31 Oct 2023Activity: Talk or presentation types › Oral presentation
-
NORDIC EMBL PARTNERSHIP MEETING 2023
Olgac, E. J. (Attendee)
11 Sept 2023 → 14 Sept 2023Activity: Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars